g plans semaglutide You've reached your weight loss goal on GLP-1 medications – what now? • Michigan Advance Semaglutide Weight Loss Program –

Novo Nordisk's investment in prescriber education and patient support programs, combined with copay assistance initiatives that reduce out-of-pocket costs for commercially insured patients, has sustained Ozempic's prescription volume even as the market has expanded

[DOI] [PubMed] [Google Scholar] 29.Adjei AA, Gaedigk A, Simon SD, Weinshilboum RM, Leeder JS

Note: Ozempic pills are not FDA-approved to treat obesity or for weight loss

Ipamorelin, by contrast, has been the compound of choice when investigators need to stimulate a discrete GH pulse with high receptor selectivity and minimal interference from concurrent cortisol or ACTH axis activation